
Meet BioConnection at BioEurope 2024
BioConnection is a trusted partner in the development and manufacturing of sterile injectable products, providing end-to-end services from early clinical development to full-scale commercial production. Our clients choose us for our flexibility, state-of-the-art facilities, and personalized approach, ensuring seamless transitions as their projects grow. At BioEurope, we’re eager to connect with innovators and decision-makers looking for a reliable partner to bring complex biopharmaceutical products to market. With our proven track record in delivering high-quality solutions, we’re ready to help accelerate the development of life-changing therapies and drive your success.
Date:
November 4-6
2024
Location:
Stockholm, Sweden
Stand number:
15
These team members will be there to connect with you:

Richard Sewalt

Ruben Teeuwen
Connect on forehand?
Please send us your personal information.
About BioConnection
BioConnection (BCO) is a specialized contract manufacturing organization (specialized CMO) serving the pharmaceutical industry. Operating from our FDA and EMA-certified facility in Oss, North Brabant, we specialize in producing injectable (bio)pharmaceutical products. Our services cover Chemistry, Manufacturing, and Controls (CMC), including drug product manufacturing process development, Fill & Finish for liquid, and freeze-drying (lyophilization) in vials and syringes. We also provide specialized small-scale (hand fill) production for personalized medicines, ensuring precision and flexibility.
At BioConnection, we support the entire drug life cycle, from producing materials for toxicology studies to clinical material manufacturing (Phase I-III) and final market production (up to 500 L). We excel in seamless project transitions, including internal technical transfers, scale-ups, and efficient preparation for Process Performance Qualification (PPQ) campaigns before market launch.
Ultimately, BioConnection drives healthcare innovation through strategic collaborations and emerging trend partnerships. While we do not engage in pharmacovigilance, our drug products are manufactured to meet strict quality standards that support this crucial aspect of the drug life cycle. We are committed to global health initiatives and sustainable manufacturing practices, improving access to life-saving medicines worldwide. Therefore, we would be delighted to discuss how we can support your projects.